Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

USP33 Inhibitors

USP33 inhibitors are a class of chemical compounds that specifically target the enzyme ubiquitin-specific protease 33 (USP33), a deubiquitinating enzyme involved in the regulation of protein turnover and cellular signaling pathways. USP33 plays a critical role in removing ubiquitin moieties from target proteins, thereby rescuing them from proteasomal degradation. This process is vital for maintaining protein homeostasis and regulating the stability of key proteins involved in various cellular processes, including signal transduction, cell cycle control, and stress responses. By inhibiting USP33, these compounds interfere with its ability to deubiquitinate substrates, leading to increased ubiquitination and subsequent degradation of target proteins.

The mechanism of action for USP33 inhibitors typically involves binding to the catalytic domain of the enzyme, blocking its activity and preventing the removal of ubiquitin from specific protein substrates. This inhibition alters the turnover rate of proteins regulated by ubiquitination, affecting downstream cellular pathways that depend on the stability of those proteins. USP33 inhibitors are valuable tools for studying the intricate dynamics of protein degradation and the role of deubiquitinating enzymes in cellular regulation. By inhibiting USP33, researchers can explore how the modulation of protein stability impacts processes such as cellular signaling, growth, and stress response. Additionally, these inhibitors provide insights into the broader ubiquitin-proteasome system and how disruptions in deubiquitination pathways influence cellular function and homeostasis.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Valproic Acid

99-66-1sc-213144
10 g
$85.00
9
(1)

Valproic Acid may downregulate USP33 by inhibiting histone deacetylases, leading to hyperacetylation of histones and suppression of gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A could decrease transcription of USP33 by preventing deacetylation of histones, thereby tightening chromatin structure near the USP33 gene.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine may reduce USP33 expression through hypomethylation of DNA, specifically within the promoter region of the USP33 gene, favoring gene silencing.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG-132 might lead to the accumulation of ubiquitinated proteins, potentially overloading the ubiquitin-proteasome pathway and reducing USP33 protein levels.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 may downregulate USP33 by inhibiting the PI3K/Akt pathway, which can trigger a cascade of transcriptional repressors to the USP33 promoter.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin could decrease USP33 protein synthesis by inhibiting mTOR, a central regulator of cellular metabolism and protein translation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib may indirectly inhibit the expression of USP33 by blocking proteasomal activity, which could disrupt various cellular signaling pathways.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid (Vorinostat) may lead to a decrease in USP33 expression by increasing the acetylation of histones, associated with repressed chromatin and lower gene activity.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin may downregulate USP33 expression by inhibiting the activation of NF-κB, which is a transcription factor that could be involved in USP33 gene transcription.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol could reduce USP33 expression through sirtuin activation, which may lead to alterations in the epigenetic landscape and suppress gene activity.